Send us a link

Subscribe to our newsletter

We need a Github of Science

We need a Github of Science

Open Science efforts like arXiv and PLoS ONE should follow GitHub’s lead and embrace the social web.

The Race For AI: Google, Twitter, Intel, Apple In A Rush To Grab Artificial Intelligence Startups

The Race For AI: Google, Twitter, Intel, Apple In A Rush To Grab Artificial Intelligence Startups

Nearly half of the AI companies acquired since 2011 have had Venture Capital backing.

10 Things to Know About How to Influence Policy with Research

10 Things to Know About How to Influence Policy with Research

Research can produce good evidence to inform local, national and international policy that, in turn, has the potential to transform lives for the better. But influencing policy is neither easy nor automatic – you need to want to do it. To be successful, you need to be open to different ways of working. Here are 10 things you need to know.

The Proposed Publishers Right Is an Attack on the Public Domain

The Proposed Publishers Right Is an Attack on the Public Domain

Traditionally, at the beginning of the new year we celebrated what is known as Public Domain Day: on the first of January of any given year the works of authors who have been dead for more than 70 years enter the public domain. As this is a decisive year for copyright reform in the European Union, it seems much more important to highlight the dangers for the public domain that we are facing in the context of the copyright reform process.

To Spark Medical Innovation, Canada Should Embrace Open Science

To Spark Medical Innovation, Canada Should Embrace Open Science

The Canadian government is again in the midst of its annual consultations on innovation. It seems our efforts to find the magic key to an “innovative economy” just never go away. By Aled Edwards, CEO of the Structural Genomics Consortium and professor at the University of Toronto.

Does Peer Review Help Weed Out Bad Science?

Does Peer Review Help Weed Out Bad Science?

Peer-review had a role to play when journals were all in print and competing for subscription real estate, but today it may be little more than a vestige of the print era.

Academia in 3 Nations Boycotts Elsevier for High Journal Prices

Academia in 3 Nations Boycotts Elsevier for High Journal Prices

Scientists in Taiwan, Germany, and Peru will lose access to more than 12,000 scientific journals after institutions boycott the publishing giant for high prices and minimal open-access options.

ScienceDisrupt Picks From 2016

ScienceDisrupt Picks From 2016

We wanted to share with you some of the awesome science innovations and disruptors from the last year. This is our list.

Why Scientists Must Learn to Communicate With the Public

Why Scientists Must Learn to Communicate With the Public

Evading science communication simply because it is difficult, time-consuming or not important enough reflects more on how much scientists value their own work and its place in posterity.

Simple and Declarative Titles Are More Likely To Be in the Altmetric Top 100

Simple and Declarative Titles Are More Likely To Be in the Altmetric Top 100

A study that assesses which specific title characteristics influence the likelihood of being included in the “Altmetric Top 100”.

What Happens to Rejected Papers?

What Happens to Rejected Papers?

Neuroskeptic« No Need To Worry About False Positives in fMRI?What Happens to Rejected Papers?By Neuroskeptic | January 3, 2017 2:43 pm32The pain of rejection is one that every scientist has felt: but what happens to papers after they’re declined by a journal?In a new study, researchers Earnshaw et al. traced the fate of almost 1,000 manuscripts which had been submitted to and rejected by ear, nose and throat journal Clinical Otolaryngology between 2011 to 2013.

Musings about the Open Science Prize

Musings about the Open Science Prize

As I was thinking about casting my vote for the Open Science Prize, I realized that I would in fact need a rubric for choosing. I was concerned that the public vote would tend towards popularity, familiarity, or bling, rather than the quality of the open science. But what does it mean to be “quality open science?” What should be the most important criteria?

Lessons From Serving on NSF Panels

Lessons From Serving on NSF Panels

Last year, I served on a couple NSF panels*, and I’d like to share some thoughts. Instead of a coherent narrative, I’ll just give a bulleted set of observations and ideas.

Top 16 Research Tools of 2016

Top 16 Research Tools of 2016

A roundup of the top trending online tools of 2016 that were most appreciated and used by the LabWorm community.

Who Will Be The Next Director of the NIH?

Who Will Be The Next Director of the NIH?

This January will not only mark a new year but a new administration and with that over 4000 new presidential appointees across the federal government.  One appointment that has the potential to either hinder or benefit the biomedical research community is that of the director of the National Institutes of Health.

AAAS CEO to Young Scientists: Speak Up. Keep Focused. Carry On.

AAAS CEO to Young Scientists: Speak Up. Keep Focused. Carry On.

Rush Holt, former Congressman, physicist and CEO of the American Association for the Advancement of Science (AAAS), explains how scientists should move forward under the Trump Administration.

Ushering in a Bold New Era for Open Science

Ushering in a Bold New Era for Open Science

Earlier this year, the Montreal Neurological Institute announced an ambitious commitment to the principles of open science. The Neuro will be eschewing patents for its discoveries and doing all it can to make its research findings widely available. While there have been other large-scale open science initiatives the Neuro is the first major research institute of its kind to make such a wide-ranging commitment to open science.